Schedule 13D ownership disclosure

Sucampo Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 864909106

Event date: 2015-08-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-465382
Form type
SC 13D
Filer
S&R Foundation
CIK
CIK 1614000
Filed
Feb 16, 2016
Reporting period
Aug 27, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub